- Home
- VSCO vs OCUL Comparison
VSCO vs OCUL Comparison
Compare VSCO & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSCO
- OCUL
- Stock Information
- Founded
- VSCO 1977
- OCUL 2006
- Country
- VSCO United States
- OCUL United States
- Employees
- VSCO N/A
- OCUL N/A
- Industry
- VSCO Clothing/Shoe/Accessory Stores
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- VSCO Consumer Discretionary
- OCUL Health Care
- Exchange
- VSCO Nasdaq
- OCUL Nasdaq
- Market Cap
- VSCO 2.1B
- OCUL 2.3B
- IPO Year
- VSCO N/A
- OCUL 2014
- Fundamental
- Price
- VSCO $28.44
- OCUL $11.26
- Analyst Decision
- VSCO Hold
- OCUL Strong Buy
- Analyst Count
- VSCO 12
- OCUL 9
- Target Price
- VSCO $26.50
- OCUL $22.13
- AVG Volume (30 Days)
- VSCO 2.4M
- OCUL 3.2M
- Earning Date
- VSCO 08-28-2025
- OCUL 11-13-2025
- Dividend Yield
- VSCO N/A
- OCUL N/A
- EPS Growth
- VSCO 6.76
- OCUL N/A
- EPS
- VSCO 1.86
- OCUL N/A
- Revenue
- VSCO $6,265,000,000.00
- OCUL $56,664,000.00
- Revenue This Year
- VSCO $3.84
- OCUL N/A
- Revenue Next Year
- VSCO $2.44
- OCUL $18.87
- P/E Ratio
- VSCO $15.34
- OCUL N/A
- Revenue Growth
- VSCO 2.29
- OCUL N/A
- 52 Week Low
- VSCO $13.76
- OCUL $5.79
- 52 Week High
- VSCO $48.73
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- VSCO 63.93
- OCUL 41.98
- Support Level
- VSCO $25.09
- OCUL $10.85
- Resistance Level
- VSCO $30.00
- OCUL $11.77
- Average True Range (ATR)
- VSCO 1.14
- OCUL 0.72
- MACD
- VSCO 0.11
- OCUL -0.16
- Stochastic Oscillator
- VSCO 71.08
- OCUL 28.63
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.